Year
2012
Status
Exited
Team
Field
Peptide technology
Location
Groningen (The Netherlands)
Fund
BGV I
Lanthio
Lanthio Pharma discovers and develops Lanthiopeptides, a new class of peptides with high target selectivity and improved “drug-like” properties. Lanthio pharma was acquired by Morphosys in 2015.